MedPath

A Study to Assess the Pain Perception during Administration of Intramuscular Injection of Benzathine Penicillin with cold needle in Rheumatic Heart Disease Patients.

Phase 4
Completed
Conditions
Health Condition 1: null- Rheumatic Heart Disease Patients receiving Benzathine Penicillin Injection every 3 weekly
Registration Number
CTRI/2017/08/009501
Lead Sponsor
isha Thomas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
95
Inclusion Criteria

1.Patients and parents giving informed consent.

2.Patients receiving benzathine penicillin intramuscular injection every 21 days and capable of giving adequate response.

3.Absence of any problem/ conditions resulting in pain.

Exclusion Criteria

1.Muscular dystrophies

2.Disoriented patients

3.Diabetic neuropathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath